GE HealthCare Stock - Saturday view on business model and earnings path

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 08:35 UTC. Details in the imprint.

GE HealthCare (US36266G1076) is one of the larger pure-play medical technology names on the Nasdaq, operating across imaging, diagnostics and patient monitoring. Analyst data indicate steady earnings growth expectations over the next year, underscoring its position as a core healthcare equipment stock.

Long-term earnings expectations

Consensus figures compiled by MarketBeat point to earnings per share rising from about $4.89 to $5.36 over the next year for GE HealthCare, an increase of roughly 9.6%. That implies investors still price in moderate growth despite a mature equipment base.

This projected expansion comes after the group’s carve-out from General Electric and reflects expectations for stable demand in diagnostic imaging and hospital technology, even as capital budgets remain under scrutiny in many health systems.

Business model and structural drivers

GE HealthCare generates revenue primarily by selling large diagnostic imaging systems, ultrasound devices and patient monitoring solutions, alongside recurring income from service contracts and consumables. These service and software elements typically support more resilient margins over the cycle.

The company also invests in digital platforms that connect imaging hardware with data analytics and workflow tools, aiming to help hospitals run scanners more efficiently and interpret images faster. This digital layer is increasingly central to differentiation in the diagnostic equipment market.

The product behind the stock

One representative product line is the GE HealthCare Revolution CT family of computed tomography scanners, used in hospitals worldwide for fast, high-resolution imaging of organs, blood vessels and bones. It anchors the company’s high-end imaging portfolio alongside MRI and ultrasound systems.

Where the stock trades today

GE HealthCare stock (US36266G1076) most recently traded on Nasdaq at around the low-$60s per share in USD as of 06/18/2026, 16:00 ET, based on recent quote data.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.